These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 9427794

  • 21. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
    Nobile MT, Barzacch MC, Sanguineti O, Chiara S, Gozza A, Vincenti M, Lavarello A, Cognein P, Lionetto R, Percivale PL, Bertoglio S, Murolo C, Esposito M, Vannozzi MO, Rosso R.
    Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
    Hsiao SM, Chen CA, Hsu C, Lin HH, Hsieh CY, Wei LH.
    Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
    [Abstract] [Full Text] [Related]

  • 25. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
    Sobrero A, Guglielmi A, Cirillo M, Recaldin E, Frassineti GL, Aschele C, Ravaioli A, Testore P, Caroti C, Gallo L, Pessi MA, Cortesi E, Turci D, Grossi F, Labianca R.
    Br J Cancer; 2001 Apr 20; 84(8):1023-8. PubMed ID: 11308248
    [Abstract] [Full Text] [Related]

  • 26. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C.
    Cancer Invest; 1999 Apr 20; 17(1):1-9. PubMed ID: 10999043
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
    Hochster H, Chachoua A, Speyer J, Escalon J, Zeleniuch-Jacquotte A, Muggia F.
    J Clin Oncol; 2003 Jul 15; 21(14):2703-7. PubMed ID: 12860947
    [Abstract] [Full Text] [Related]

  • 33. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH, Chen KY.
    Cancer; 1995 Dec 01; 76(11):2186-92. PubMed ID: 8635020
    [Abstract] [Full Text] [Related]

  • 34. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Konishi K, Yabushita K, Taguchi T, Ota J, Takashima S, Abe T, Kikkawa N, Yasutomi M, Sowa M, Maehara Y.
    Gan To Kagaku Ryoho; 1995 Jun 01; 22(7):925-32. PubMed ID: 7793998
    [Abstract] [Full Text] [Related]

  • 35. Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.
    Martoni A, Cricca A, Guaraldi M, Covizzi M, Farris A, Pannuti F.
    Anticancer Res; 1992 Jun 01; 12(3):607-12. PubMed ID: 1622115
    [Abstract] [Full Text] [Related]

  • 36. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M, Jaehde U, Stremetzne S, Ridwelski K, Kerz H, Strohbach F, Hohenberger P, Zwiebel FM, Hebart H, Böthig R, Kairies M, Zillig D, Schuchmann S, Warnecke S, Thiel E, Kreuser ED.
    Ann Oncol; 1997 Nov 01; 8(11):163-5. PubMed ID: 9426339
    [Abstract] [Full Text] [Related]

  • 37. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
    Takahashi N, Kunii Y, Ota K.
    Gan To Kagaku Ryoho; 1995 Dec 01; 22 Suppl 4():447-52. PubMed ID: 8849291
    [Abstract] [Full Text] [Related]

  • 38. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
    Grem JL.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
    [Abstract] [Full Text] [Related]

  • 39. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T, Futatsuki K, Akazawa S, Yamamoto K, Miyazaki M, Kanda Y, Amemiya K, Uchida N, Oishi T.
    Gan To Kagaku Ryoho; 1993 Apr 01; 20(5):603-9. PubMed ID: 8470917
    [Abstract] [Full Text] [Related]

  • 40. Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer.
    Wilke H, Korn M, Vanhöfer U, Fink U, Stahl M, Preusser P, Köhne C, Klassen U, Harstrick A, Schmoll HJ, Seeber S.
    J Infus Chemother; 1996 Apr 01; 6(3):123-6. PubMed ID: 9229322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.